RecruitingNCT05885646

Effect of Sulthiame on EEG in Childhood Epilepsy Syndromes

Treatment of Epilepsy Syndromes of Childhood With Sleep Activation Using Sulthiame: an Exploratory Study of the Short Term Effect on EEG


Sponsor

University Hospital, Angers

Enrollment

15 participants

Start Date

Oct 17, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The effect of sulthiame on EEG has been studied in epilepsy syndromes of childhood with sleep activation by comparing sleep EEG obtained at baseline and after 4 weeks of treatment. The aim of the study is to know if an effect is still identifiable after 2 weeks of treatment by performing sleep EEG recordings after 2 and 4 weeks of treatment, respectively.


Eligibility

Min Age: 6 YearsMax Age: 15 Years

Inclusion Criteria3

  • Diagnosis of epilepsy syndromes of childhood with sleep activation
  • Failure of at least two anti-epileptic drugs (AED)
  • Sleep EEG performed in the last 7 days before inclusion and showing interictal epileptiform discharges (baseline EEG)

Exclusion Criteria4

  • Previous trial with sulthiame
  • More than 2 AED at inclusion
  • Use of corticosteroids at inclusion
  • Change in the anti-epileptic treatment in the 7 days before baseline EEG

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSulthiame

Sulthiame add-on according to good clinical practice in these childhood epilepsy syndromes


Locations(3)

Angers University Hospital, Pediatric department

Angers, France

Strasbourg University Hospital, Pediatric department

Strasbourg, France

Toulouse University Hospital, Pediatric Neurology Department

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05885646


Related Trials